DEVELOPMENT OF LIPOSOME FORMULATIONS CO-ENCAPSULATING TOPOISOMERASE INHIBITORS IRINOTECAN AND DOXORUBICIN FOR THE TREATMENT OF OVARIAN CANCER

Ph.D

Saved in:

Bibliographic Details
Main Author:	SHAIKH MOHAMMED ISHAQUE
Other Authors:	PHARMACY
Format:	Theses and Dissertations
Language:	English
Published:	2012
Subjects:	Ovarian cancer,doxorubicin,irinotecan,synergism,liposome
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/29984
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-29984
record_format	dspace
spelling	sg-nus-scholar.10635-299842017-10-21T08:03:05Z DEVELOPMENT OF LIPOSOME FORMULATIONS CO-ENCAPSULATING TOPOISOMERASE INHIBITORS IRINOTECAN AND DOXORUBICIN FOR THE TREATMENT OF OVARIAN CANCER SHAIKH MOHAMMED ISHAQUE PHARMACY CHIU NGAR CHEE, GIGI Ovarian cancer,doxorubicin,irinotecan,synergism,liposome Ph.D DOCTOR OF PHILOSOPHY 2012-01-03T18:00:21Z 2012-01-03T18:00:21Z 2011-08-19 Thesis SHAIKH MOHAMMED ISHAQUE (2011-08-19). DEVELOPMENT OF LIPOSOME FORMULATIONS CO-ENCAPSULATING TOPOISOMERASE INHIBITORS IRINOTECAN AND DOXORUBICIN FOR THE TREATMENT OF OVARIAN CANCER. ScholarBank@NUS Repository. http://scholarbank.nus.edu.sg/handle/10635/29984 NOT_IN_WOS en
institution	National University of Singapore
building	NUS Library
country	Singapore
collection	ScholarBank@NUS
language	English
topic	Ovarian cancer,doxorubicin,irinotecan,synergism,liposome
spellingShingle	Ovarian cancer,doxorubicin,irinotecan,synergism,liposome SHAIKH MOHAMMED ISHAQUE DEVELOPMENT OF LIPOSOME FORMULATIONS CO-ENCAPSULATING TOPOISOMERASE INHIBITORS IRINOTECAN AND DOXORUBICIN FOR THE TREATMENT OF OVARIAN CANCER
description	Ph.D
author2	PHARMACY
author_facet	PHARMACY SHAIKH MOHAMMED ISHAQUE
format	Theses and Dissertations
author	SHAIKH MOHAMMED ISHAQUE
author_sort	SHAIKH MOHAMMED ISHAQUE
title	DEVELOPMENT OF LIPOSOME FORMULATIONS CO-ENCAPSULATING TOPOISOMERASE INHIBITORS IRINOTECAN AND DOXORUBICIN FOR THE TREATMENT OF OVARIAN CANCER
title_short	DEVELOPMENT OF LIPOSOME FORMULATIONS CO-ENCAPSULATING TOPOISOMERASE INHIBITORS IRINOTECAN AND DOXORUBICIN FOR THE TREATMENT OF OVARIAN CANCER
title_full	DEVELOPMENT OF LIPOSOME FORMULATIONS CO-ENCAPSULATING TOPOISOMERASE INHIBITORS IRINOTECAN AND DOXORUBICIN FOR THE TREATMENT OF OVARIAN CANCER
title_fullStr	DEVELOPMENT OF LIPOSOME FORMULATIONS CO-ENCAPSULATING TOPOISOMERASE INHIBITORS IRINOTECAN AND DOXORUBICIN FOR THE TREATMENT OF OVARIAN CANCER
title_full_unstemmed	DEVELOPMENT OF LIPOSOME FORMULATIONS CO-ENCAPSULATING TOPOISOMERASE INHIBITORS IRINOTECAN AND DOXORUBICIN FOR THE TREATMENT OF OVARIAN CANCER
title_sort	development of liposome formulations co-encapsulating topoisomerase inhibitors irinotecan and doxorubicin for the treatment of ovarian cancer
publishDate	2012
url	http://scholarbank.nus.edu.sg/handle/10635/29984
_version_	1681080912431808512

DEVELOPMENT OF LIPOSOME FORMULATIONS CO-ENCAPSULATING TOPOISOMERASE INHIBITORS IRINOTECAN AND DOXORUBICIN FOR THE TREATMENT OF OVARIAN CANCER

Similar Items